Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -33.788% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC1CN(C(=O)CCC(=O)NCCCc2ccccc2)c2ccccc2O1
b Cc1c(N=Nc2c(O)[nH]c(=S)[nH]c2=O)c(=O)n(-c2ccccc2)n1C
c COc1cc2c(cc1OC)C(c1ccc(Br)cc1)NC(=O)C2
Answer: a. CC1CN(C(=O)CCC(=O)NCCCc2ccccc2)c2ccccc2O1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CN(C(=O)CCC(=O)NCCCc2ccccc2)c2ccccc2O1
CC1CN(C(=O)CCC(=O)NCCCc2ccccc2)c2ccccc2O1
4-(2-methyl-2,3-dihydro-1,4-benzoxazin-4-yl)-4-oxo-N-(3-phenylpropyl)butanamide